Company news
Venus Medtech (hangzhou), Inc. Class H (HKEX:2500) news
Venus Medtech (hangzhou), Inc. Class H news releases on 6ix. Latest, Sep 30, 2026: POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING
Press releases & updates
POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING
September 30, 2026
Cardiovalve Completes TARGET Study Enrollment for CE Registration Study for Tricuspid Valve Replacement
October 25, 2025
Court Sides with Cardiovalve in Edwards patent spat
August 5, 2025
Venus Medtech Reports 2024 Annual Results: Profitability Surges with Robust Global Expansion and Innovations
April 21, 2025
Venus Medtech Concludes Acquisition of 100% Equity Interest in Cardiovalve
January 24, 2022
Venus Medtech Acquires Cardiovalve to Optimize its Innovative Products Pipeline of Mitral and Tricuspid Valve Replacement
December 6, 2021